Saragossa, Spain

Maria Virtudes Cespedes Navarro


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Zaragoza, ES (2019)
  • Saragossa, ES (2020 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Maria Virtudes Cespedes Navarro: Innovator in Targeted Therapeutics

Introduction

Maria Virtudes Cespedes Navarro is a prominent inventor based in Saragossa, Spain. She has made significant contributions to the field of therapeutic delivery systems, holding a total of 3 patents. Her work focuses on innovative methods and reagents that enhance the targeted delivery of therapeutic molecules.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells." This patent describes conjugates that comprise a targeting moiety specific for the CXCR4 receptor, utilizing a polyphemusin-derived peptide along with a therapeutic or imaging agent. The patent also outlines therapeutic and diagnostic methods that require specific targeting to CXCR4+ cells, showcasing her commitment to advancing medical science.

Career Highlights

Maria has worked with esteemed institutions such as Universitat Autonoma De Barcelona and Institut Recerca Hospital De La Santa Creu I Sant Pau. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to significant advancements in therapeutic technologies.

Collaborations

Some of her notable coworkers include Antonio Pedro Villaverde Corrales and Esther Vazquez Gomez. Their collaborative efforts have further enriched the research and development of targeted therapeutic solutions.

Conclusion

Maria Virtudes Cespedes Navarro stands out as an influential inventor in the realm of targeted therapeutics. Her innovative patents and collaborations reflect her dedication to improving healthcare through advanced scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…